COPD is a group of progressive lung diseases that includes emphysema and chronic bronchitis. Despite affecting an estimated 32 million people in the United States, as many as half are unaware they ...

Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in ...

The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic ...

Chronic obstructive pulmonary disease (COPD) affects millions of Americans, with new data from the National Center for Health Statistics showing the condition becomes increasingly common as people age ...

University of Alabama at Birmingham-led researchers have refined and validated a new framework for diagnosing chronic ...

My cat coughing up phlegm: understand the underlying causes and learn evidence-based treatment methods to ensure your cat's well-being.

The Australian state is grappling with a widespread dust storm days after record flooding that killed five and displaced ...

The US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive ...

Cheap, durable, and low maintenance — synthetic fibres offer the kind of convenience modern life thrives on. However, beneath ...

Children and adolescents with asthma are especially vulnerable. Exposure to e-cigarette aerosols can trigger asthma attacks, reduce medication effectiveness, impair lung function, and slow lung ...

GSK’s Nucala receives US FDA approval for use in adults with chronic obstructive pulmonary disease: London, UK Saturday, May 24, 2025, 11:00 Hrs [IST] GSK plc announced that the ...

Patients with COPD and type 2 inflammation receiving mepolizumab vs. placebo had decreased moderate and severe exacerbation ...